Products
Online Inquiry
MK-5046
Inquiry
Cat. No.:
OB0425LY-136
Synonyms:
1022152-70-0; MK5046; (2S)-1,1,1-trifluoro-2-(4-pyrazol-1-ylphenyl)-3-[5-[[1-(trifluoromethyl)cyclopropyl]methyl]-1H-imidazol-2-yl]propan-2-ol; (2S)-1,1,1-Trifluoro-2-(4-(1H-pyrazol-1-yl)phenyl)-3-(4-((1-(trifluoromethyl)cyclopropyl)methyl)-1H-imidazol-2-yl)propan-2-ol; (S)-2-(4-(1H-pyrazol-1-yl)phenyl)-1,1,1-trifluoro-3-(5-((1-(trifluoromethyl)cyclopropyl)methyl)-1H-imidazol-2-yl)propan-2-ol; 1H-Imidazole-2-ethanol, a-[4-(1H-pyrazol-1-yl)phenyl]-a-(trifluoromethyl)-5-[[1-(trifluoromethyl)cyclopropyl]methyl]-, (aS)-
Size:
1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 200 mg; 500 mg
CAS No.:
1022152-70-0
Compound CID:
49871766
Specification
Description:
MK-5046 is a selective Bombesin receptor subtype-3 (BRS-3) allosteric agonist that inhibits food intake in mouse models.
Formula Weight:
444.37
Applications:
MK-5046 is commonly used in studies for the treatment of diabetes, obesity and other metabolic diseases.
Storage:
Storage at -20°C.
Formula:
C20H18F6N4O
Appearance:
Solid
Purity:
99.6%, determined by LC-MS.
Solubility:
DMSO
Pathway:
GPCR/G protein
Identity:
Confirmed by LC-MS.
Target:
Bombesin receptor
Library Information
Solubility:
DMSO